Nebraska Legislature - Lobbyist Reporting Application

Clerk of the Legislature

Room 2014 State Capitol

PO Box 94604

Lincoln, NE 68509

(402) 471-2608

NEBRASKA LOBBYIST
STATEMENT of ACTIVITY

NADC FORM D

Submission Date: Jul 13, 2023

Each registered lobbyist shall file a Statement of Activity within 45 days after the end of a regular session of the Legislature. The statement must be filed even if the lobbyist engaged in no activity.
Any registered lobbyist who engages in lobbying activity in connection with a special session of the Legislature shall file a Statement of Activity within 45 days after the end of the special session. Late filing fees are $25.00 per day, not to exceed $750.00.
Lobbyists having more than one principal shall file a separate report for each principal.

ITEM 1

NATURE OF FILING (Check appropriate box)

For Calendar Year of

2023

Regular Session

Special Session

Amended Report

ITEM 2

NAME OF LOBBYIST AND PRINCIPAL

LOBBYIST

Lobbyist Name

Husch Blackwell Strategies

Phone

(402) 434-8040

Address

1630 K Street

City

Lincoln

State

Zip

68508

PRINCIPAL

Principal Name

Blue Cross and Blue Shield of Nebraska

Office Phone

(402) 982-7000

Office Address (Street, Box, or Route)

1919 Aksarben Drive

City

Omaha

State

Zip

68180

List all the legislation upon which the lobbyist acted on behalf of the principal including bills, resolutions, amendments and procedural matters. Identify by number of bill, resolution, amendment or procedural matter and state the position taken. This statement should include a list of amendments or procedural matters which the lobbyist has acted upon for the principal, even if the lobbyist has not acted upon the bill or resolution from which the amendment or procedural matter arises.

Identify bill or resolution number	Describe bill, resolution, amendment or procedural matter	Position taken
LB32	Change requirements for issuers of medicare supplement insurance policies or certificates relating to coverage of individuals under sixty-five years of age who are eligible for medicare by reason of disability or end-stage renal disease	Neutral
LB46	Appropriate funds to the Department of Health and Human Services for a provider rate study	Neutral
LB57	Adopt the Paid Family and Medical Leave Insurance Act	Oppose
LB62	Provide for coverage of translation and interpretation services under the medical assistance program	Neutral
LB79	Adopt the Nebraska EPIC Option Consumption Tax Act	Oppose
LB142	Limit the amount an insured pays for prescription insulin drugs	Neutral
LB145	Change provisions relating to coverage for screening mammography and breast examinations	Neutral
LB181	Provide for filling and refilling prescriptions in certain circumstances	Neutral
LB200	Adopt the Canadian Prescription Drug Importation Act	Oppose
LB204	Provide for reimbursement for pharmacy dispensing fees under the medical assistance program	Neutral
LB210	Adopt the Prior Authorization Reform Act	Oppose
LB256	Change provisions related to insurance coverage of telehealth	Oppose
LB383	Change provisions relating to insurance coverage for screenings for colorectal cancer	Neutral
LB392	Authorize the electronic delivery of certain health benefit plan documents	Support
LB430	Prohibit a multiple procedure payment reduction policy from being applied to physical therapy, occupational therapy, or speech-language pathology services as prescribed under the Uniform Credentialing Act	Oppose
LB448	Prohibit certain provisions in a health plan in relation to clinician-administered drugs	Oppose
LB458	Allow certain central fill pharmacies to deliver to a patient under the Prescription Drug Safety Act	Neutral
LB640	Require an off-campus location of a hospital to obtain and use a separate National Provider Identifier in billing for health care services	Support
LB778	Change the Pharmacy Benefit Manager Licensure and Regulation Act	Oppose
LB779	Limit the amount an insured pays for prescription insulin drugs	Oppose

I certify that all information presented in this form is accurate to the best of my knowledge.

HBS

Lobbyist Name

Jul 13, 2023

Date